IMMUNOLOGICAL MONITORING DURING AND AFTER OKT3 THERAPY

被引：31

作者：

SHIELD, CF

NORMAN, DJ

机构：

[1] UNIV KANSAS,SCH MED,DEPT SURG,WICHITA,KS

[2] OREGON HLTH SCI CTR,DEPT MED,PORTLAND,OR

来源：

AMERICAN JOURNAL OF KIDNEY DISEASES | 1988年 / 11卷 / 02期

关键词：

D O I：

10.1016/S0272-6386(88)80193-8

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：120 / 124

页数：5

相关论文

共 8 条

[1] GOLDSTEIN G, 1985, NEW ENGL J MED, V313, P337
[2] Goldstein G, 1986, Prog Clin Biol Res, V224, P239
[3] OKT3 MONOCLONAL-ANTIBODY PLASMA-LEVELS DURING THERAPY AND THE SUBSEQUENT DEVELOPMENT OF HOST ANTIBODIES TO OKT3
GOLDSTEIN, G
FUCCELLO, AJ
NORMAN, DJ
SHIELD, CF
COLVIN, RB
COSIMI, AB
[J]. TRANSPLANTATION, 1986, 42 (05) : 507 - 511
[4] LAZAROVITS AI, IN PRESS TRANSPLANTA
[5] NORMAN DJ, 1986, TRANSPLANT P, V18, P949
[6] STABILITY OF HUMAN-LYMPHOCYTE DIFFERENTIATION ANTIGENS WHEN STORED AT ROOM-TEMPERATURE
SHIELD, CF
MARLETT, P
SMITH, A
GUNTER, L
GOLDSTEIN, G
[J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1983, 62 (03) : 347 - 352
[7] SHIELD CF, 1987, TRANSPLANT P, V19, P2217
[8] PROPHYLACTIC USE OF OKT3 MONOCLONAL-ANTIBODY IN CADAVER KIDNEY RECIPIENTS - UTILIZATION OF OKT3 AS THE SOLE IMMUNOSUPPRESSIVE AGENT
VIGERAL, P
CHKOFF, N
CHATENOUD, L
CAMPOS, H
LACOMBE, M
DROZ, D
GOLDSTEIN, G
BACH, JF
KREIS, H
[J]. TRANSPLANTATION, 1986, 41 (06) : 730 - 733